Ye Siqin, Wang Y Claire, Shimbo Daichi, Newman Jonathan D, Levitan Emily B, Muntner Paul
Department of Medicine, Center for Behavioral Cardiovascular Health, Columbia University, New York, NY.
Department of Health Policy & Management, Mailman School of Public Health, Columbia University, New York, NY.
J Am Soc Hypertens. 2014 Mar;8(3):159-65. doi: 10.1016/j.jash.2013.12.006. Epub 2013 Dec 19.
Systolic blood pressure (SBP) often varies between clinic visits within individuals, which can affect estimation of cardiovascular disease (CVD) risk. We analyzed data from participants with two clinic visits separated by a median of 17 days in the Third National Health and Nutrition Examination Survey (n = 808). Ten-year CVD risk was calculated with SBP obtained at each visit using the Pooled Cohort Equations. The mean age of participants was 46.1 years, and 47.3% were male. The median SBP difference between the two visits was -1 mm Hg (1st to 99th percentiles: -23 to 32 mm Hg). The median estimated 10-year CVD risk was 2.5% and 2.4% at the first and second visit, respectively (1st to 99th percentiles -5.2% to +7.1%). Meaningful risk reclassification (ie, across the guideline recommended 7.5% threshold for statin initiation) occurred in 12 (11.3%) of 106 participants whose estimated CVD risk was between 5% and 10%, but only in two (0.3%) of 702 participants who had a 10-year estimated CVD risk of <5% or >10%. SBP variability can affect CVD risk estimation, and can influence statin eligibility for individuals with an estimated 10-year CVD risk between 5% and 10%.
收缩压(SBP)在个体的不同门诊就诊期间常常会有所变化,这可能会影响心血管疾病(CVD)风险的评估。我们分析了第三次全国健康与营养检查调查中两次门诊就诊间隔中位数为17天的参与者的数据(n = 808)。使用合并队列方程,根据每次就诊时测得的收缩压计算10年心血管疾病风险。参与者的平均年龄为46.1岁,男性占47.3%。两次就诊之间收缩压的中位数差异为-1 mmHg(第1至第99百分位数:-23至32 mmHg)。首次和第二次就诊时估计的10年心血管疾病风险中位数分别为2.5%和2.4%(第1至第99百分位数:-5.2%至+7.1%)。在估计心血管疾病风险在5%至10%之间的106名参与者中,有12名(11.3%)发生了有意义的风险重新分类(即跨越指南推荐的启动他汀类药物治疗的7.5%阈值),但在估计10年心血管疾病风险<5%或>10%的702名参与者中,只有2名(0.3%)发生了这种情况。收缩压变异性会影响心血管疾病风险评估,并可能影响估计10年心血管疾病风险在5%至10%之间的个体使用他汀类药物的资格。